Oral transmucosal delivery of eletriptan for neurological diseases

Sabrina Valetti, Azra Riaz, Anemona Doko, Kaiser Sultana, Mahboubeh Eskandari, Zdenka Prgomet, Adam Feiler, Robert Rönn, Bengt Dahlström, Johan Engblom, Sebastian Björklund

Open source

DOI: 10.1016/j.ijpharm.2022.122222
Published: 2022-11
Container: International Journal of Pharmaceutics
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2022.122222,
  title = {Oral transmucosal delivery of eletriptan for neurological diseases},
  author = {Sabrina Valetti and Azra Riaz and Anemona Doko and Kaiser Sultana and Mahboubeh Eskandari and Zdenka Prgomet and Adam Feiler and Robert Rönn and Bengt Dahlström and Johan Engblom and Sebastian Björklund},
  year = {2022},
  journal = {International Journal of Pharmaceutics},
  doi = {10.1016/j.ijpharm.2022.122222},
  url = {https://doi.org/10.1016/j.ijpharm.2022.122222}
}

RIS

TY  - JOUR
TI  - Oral transmucosal delivery of eletriptan for neurological diseases
AU  - Sabrina Valetti
AU  - Azra Riaz
AU  - Anemona Doko
AU  - Kaiser Sultana
AU  - Mahboubeh Eskandari
AU  - Zdenka Prgomet
AU  - Adam Feiler
AU  - Robert Rönn
AU  - Bengt Dahlström
AU  - Johan Engblom
AU  - Sebastian Björklund
PY  - 2022
JO  - International Journal of Pharmaceutics
DO  - 10.1016/j.ijpharm.2022.122222
UR  - https://doi.org/10.1016/j.ijpharm.2022.122222
ER  -

APA

Valetti, S., Riaz, A., Doko, A., Sultana, K., Eskandari, M., Prgomet, Z., Feiler, A., Rönn, R., Dahlström, B., Engblom, J., & Björklund, S. (2022). Oral transmucosal delivery of eletriptan for neurological diseases. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2022.122222

Source records

crossref · retrieved 2026-09-26T16:28:05.541Z